Kevin J. Barnham

University of Melbourne — Australia

Medicine · Health Sciences

75h-index23.7kcitations321works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(185), Trace Elements in Health(71), Cholinesterase and Neurodegenerative Diseases(55), Computational Drug Discovery Methods(40), Parkinson's Disease Mechanisms and Treatments(27)

Publications321 total

Multiomics analysis to evaluate the enrichment of extracellular vesicles from human plasma
Journal of Lipid Research·2025· 3 citedOpen Access
The Search for Disease Modification in Parkinson’s Disease—A Review of the Literature
Life·2025· 1 citedOpen Access
Novel Therapeutics in the Search for Disease Modification in Parkinson’s Disease – a Rapid Review of the Literature
Preprints.org·2025Open Access
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer’s disease progression
Nature Communications·2024· 21 citedOpen Access
Multi-omics characterization of highly enriched human plasma extracellular vesicles
2024Open Access
Optimization of plasma extracellular vesicle enrichment for in‐depth lipidomic profiling in Alzheimer’s disease
Alzheimer s & Dementia·2023Open Access
Amyloid‐β and monocytes in Alzheimer’s disease
Alzheimer s & Dementia·2023· 1 citedOpen Access
Using <sup>18</sup> F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease
Neurology·2023· 28 citedOpen Access
Exploring the significance of lipids in Alzheimer's disease and the potential of extracellular vesicles
PROTEOMICS·2023· 11 citedOpen Access
Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice
British Journal of Pharmacology·2023· 12 citedOpen Access
The potential of extracellular vesicle lipid profiling in Alzheimer's disease.
2023Open Access
CCDC 2205695: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
CCDC 2205696: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease
Chemical Communications·2023· 8 cited
ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism
Neurotherapeutics·2022· 11 citedOpen Access
Author Correction: Asymmetric thinning of the cerebral cortex across the adult lifespan is accelerated in Alzheimer’s disease
Nature Communications·2022· 6 citedOpen Access
Loss-of-function and gain-of-function studies refute the hypothesis that tau protein is causally involved in the pathogenesis of Huntington’s disease
Human Molecular Genetics·2022· 4 citedOpen Access
Extracellular vesicular lipids as biomarkers for the diagnosis of Alzheimer’s disease
Alzheimer s & Dementia·2021· 3 cited
Quantitative proteomics of detergent insoluble tangles derived from Alzheimer’s disease brains
Alzheimer s & Dementia·2021· 1 cited
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
Acta Neuropathologica Communications·2021· 2 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Colin L. Masters(36), Ashley I. Bush(24), Roberto Cappai(18), Robert A. Cherny(15), Irene Volitakis(13), Keyla Perez(10), Qiao‐Xin Li(10), Anthony R. White(9), Giuseppe D. Ciccotosto(8), Cyril C. Curtain(8), Deborah J. Tew(8), Catriona McLean(6), Victor L. Villemagne(6), Peter J. Crouch(6), Blaine R. Roberts(6), Paul S. Donnelly(6), Paul A. Adlard(5), Katrina Laughton(5), Christopher C. Rowe(5), Andrew F. Hill(5)